These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 25962818

  • 1. Rheumatoid Arthritis - Anti-TNF.
    Chaabo K, Kirkham B.
    Int Immunopharmacol; 2015 Aug; 27(2):180-4. PubMed ID: 25962818
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis.
    Segal B, Rhodus NL, Patel K.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):778-87. PubMed ID: 18930662
    [Abstract] [Full Text] [Related]

  • 3. TNF inhibitors - new and old agents for rheumatoid arthritis.
    Simsek I.
    Bull NYU Hosp Jt Dis; 2010 Dec; 68(3):204-10. PubMed ID: 20969553
    [Abstract] [Full Text] [Related]

  • 4. The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis.
    Hernández MV, Sanmartí R, Cañete JD.
    Expert Opin Drug Saf; 2016 May; 15(5):613-24. PubMed ID: 26927029
    [Abstract] [Full Text] [Related]

  • 5. TNF inhibitors for rheumatoid arthritis - a year in review.
    Simsek I.
    Bull NYU Hosp Jt Dis; 2011 May; 69(3):220-4. PubMed ID: 22035432
    [Abstract] [Full Text] [Related]

  • 6. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F, Murdaca G, Ghio M, Indiveri F.
    Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
    [Abstract] [Full Text] [Related]

  • 7. Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis.
    Murdaca G, Spanò F, Puppo F.
    Expert Opin Drug Saf; 2013 Nov; 12(6):801-4. PubMed ID: 23889669
    [Abstract] [Full Text] [Related]

  • 8. Sequential use of biologic therapy in rheumatoid arthritis.
    Buch MH.
    Curr Opin Rheumatol; 2010 May; 22(3):321-9. PubMed ID: 20190641
    [Abstract] [Full Text] [Related]

  • 9. TNF-alpha antagonism and cancer risk in rheumatoid arthritis: is continued vigilance warranted?
    Park HJ, Ranganathan P.
    Discov Med; 2012 Mar; 13(70):229-34. PubMed ID: 22463799
    [Abstract] [Full Text] [Related]

  • 10. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM, Shalaby MA, Al-Homaid S, Mahfouz AM, Shams OA, Fathy A.
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [Abstract] [Full Text] [Related]

  • 11. TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study.
    Raaschou P, Frisell T, Askling J, ARTIS Study Group.
    Ann Rheum Dis; 2015 Dec; 74(12):2137-43. PubMed ID: 25107559
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register.
    Chatzidionysiou K, Askling J, Eriksson J, Kristensen LE, van Vollenhoven R, ARTIS group.
    Ann Rheum Dis; 2015 May; 74(5):890-6. PubMed ID: 24431398
    [Abstract] [Full Text] [Related]

  • 13. Predictors of response to TNF inhibitors in rheumatoid arthritis - do we have new tools for personalized medicine?
    Simsek I.
    Bull NYU Hosp Jt Dis; 2012 May; 70(3):187-90. PubMed ID: 23259626
    [Abstract] [Full Text] [Related]

  • 14. TNF as a Target of Inflammation in Rheumatoid Arthritis.
    Yamanaka H.
    Endocr Metab Immune Disord Drug Targets; 2015 May; 15(2):129-34. PubMed ID: 25772178
    [Abstract] [Full Text] [Related]

  • 15. [Fully human anti TNF-alpha monoclonal antibodies (adalimumab, golimumab)].
    Hirohata S.
    Nihon Rinsho; 2007 Jul; 65(7):1202-8. PubMed ID: 17642233
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y, Markovits D, Rozin A, Toledano K, Nahir AM, Balbir-Gurman A.
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [Abstract] [Full Text] [Related]

  • 17. Does anti-tumor necrosis factor-α therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm data.
    Keystone EC.
    J Rheumatol; 2011 Aug; 38(8):1552-62. PubMed ID: 21572154
    [Abstract] [Full Text] [Related]

  • 18. The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis.
    Paleolog E.
    Expert Opin Investig Drugs; 2003 Jul; 12(7):1087-95. PubMed ID: 12831345
    [Abstract] [Full Text] [Related]

  • 19. Kinoid of human tumor necrosis factor-alpha for rheumatoid arthritis.
    Semerano L, Assier E, Delavallée L, Boissier MC.
    Expert Opin Biol Ther; 2011 Apr; 11(4):545-50. PubMed ID: 21385114
    [Abstract] [Full Text] [Related]

  • 20. [How I treat...rheumatoid arthritis. The arrival of a new therapeutic era: anti-tumor necrosis factor alpha antibodies].
    Kaiser MJ, Malaise MG.
    Rev Med Liege; 2002 Aug; 57(8):486-92. PubMed ID: 12405019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.